Evidence map›Paper›PMID 38912301›Full record

ArticleFrontiers in nutrition2024

Associations of ω-3, ω-6 polyunsaturated fatty acids intake and ω-6: ω-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020.

Yifan Li, Hao Tang, Xiaotong Yang, Lili Ma, Hangqi Zhou, Guangjiang Zhang, Xin Chen, Lijun Ma, Jing Gao, Wei Ji

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yifan Li *Department of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Hao Tang *Department of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Xiaotong YangDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Lili MaDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Hangqi ZhouDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Guangjiang ZhangDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Xin ChenDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Lijun MaDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Jing GaoDepartment of Rheumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Wei JiDepartment of Rheumatology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In recent years, diseases caused by abnormal immune-inflammatory responses have become increasingly severe. Dietary intervention involving omega-3 polyunsaturated fatty acids (ω-3 PUFAs) has emerged as a potential treatment. However, research investigating the relationship between ω-3, ω-6 PUFAs, and ω-6 to ω-3 ratio with inflammatory biomarkers remains controversial. Methods: To investigate the correlation between the intake of ω-3 and ω-6 PUFAs and the ratio of ω-6: ω-3 with biomarkers of inflammation, the National Health and Nutrition Examination Survey (NHANES) data (1999 to 2020) was utilized. The systemic immune-inflammation index (SII), platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR), and white blood cell (WBC) were selected as study subjects. Dietary data for ω-3 and ω-6 PUFAs were collected via two 24-h dietary recall interviews. SII index and other indicators were obtained from the blood routine data. The multiple linear regression and restricted cubic spline models were utilized to evaluate the association of ω-3, ω-6 PUFAs intake, and ω-6: ω-3 ratio to SII and secondary measures. Results: This study involved a total of 43,155 American adults. ω-3 and ω-6 PUFAs exhibited negative correlations with SII, PLR, NLR, and WBC. The correlation between ω-6: ω-3 ratio and SII, PLR, NLR, and WBC was not significant. Furthermore, the dose-response relationship showed that the relationship between the intake of ω-3 and ω-6 PUFAs and SII was an "L" pattern. Conclusion: Intake of dietary ω-3 and ω-6 PUFAs reduces the levels of several inflammatory biomarkers in the body and exerts immunomodulatory effects.

Indexed as

neutrophil-to-lymphocyte ratioNHANESplatelet-lymphocyte ratiosystemic immune-inflammation indexwhite blood cellω-3 PUFAsω-6 PUFAsω-6: ω-3 ratio

Identifiers

PMID38912301
PMCPMC11190316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.